Cargando…
Small molecules targeting protein–protein interactions for cancer therapy
Protein–protein interactions (PPIs) are fundamental to many biological processes that play an important role in the occurrence and development of a variety of diseases. Targeting the interaction between tumour-related proteins with emerging small molecule drugs has become an attractive approach for...
Autores principales: | Wu, Defa, Li, Yang, Zheng, Lang, Xiao, Huan, Ouyang, Liang, Wang, Guan, Sun, Qiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547922/ https://www.ncbi.nlm.nih.gov/pubmed/37799384 http://dx.doi.org/10.1016/j.apsb.2023.05.035 |
Ejemplares similares
-
Small molecules targeting the NEDD8·NAE protein–protein interaction
por: Lin, Chen-Ming, et al.
Publicado: (2020) -
Small Molecules as Protein-Protein Interaction Inhibitors
por: Hajimahdi, Zahra
Publicado: (2016) -
Small Molecule Targeting of Protein–Protein Interactions through Allosteric Modulation of Dynamics
por: Cossins, Benjamin P., et al.
Publicado: (2015) -
Small-molecule inhibitor targeting the Hsp90-Cdc37 protein-protein interaction in colorectal cancer
por: Wang, Lei, et al.
Publicado: (2019) -
Small-Molecule Inhibitors That Target Protein–Protein Interactions in the RAD51 Family of Recombinases
por: Scott, Duncan E, et al.
Publicado: (2015)